152 related articles for article (PubMed ID: 29923609)
1. Mini-review: Update on the genetics of schizophrenia.
Coelewij L; Curtis D
Ann Hum Genet; 2018 Sep; 82(5):239-243. PubMed ID: 29923609
[TBL] [Abstract][Full Text] [Related]
2. Resequencing and association analysis of coding regions at twenty candidate genes suggest a role for rare risk variation at AKAP9 and protective variation at NRXN1 in schizophrenia susceptibility.
Suárez-Rama JJ; Arrojo M; Sobrino B; Amigo J; Brenlla J; Agra S; Paz E; Brión M; Carracedo Á; Páramo M; Costas J
J Psychiatr Res; 2015; 66-67():38-44. PubMed ID: 25943950
[TBL] [Abstract][Full Text] [Related]
3. Molecular pathways involved in neuronal cell adhesion and membrane scaffolding contribute to schizophrenia and bipolar disorder susceptibility.
O'Dushlaine C; Kenny E; Heron E; Donohoe G; Gill M; Morris D; ; Corvin A
Mol Psychiatry; 2011 Mar; 16(3):286-92. PubMed ID: 20157312
[TBL] [Abstract][Full Text] [Related]
4. Rare NRXN1 promoter variants in patients with schizophrenia.
Shah AK; Tioleco NM; Nolan K; Locker J; Groh K; Villa C; Stopkova P; Pedrosa E; Lachman HM
Neurosci Lett; 2010 May; 475(2):80-4. PubMed ID: 20347009
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide Analysis of the Role of Copy Number Variation in Schizophrenia Risk in Chinese.
Li Z; Chen J; Xu Y; Yi Q; Ji W; Wang P; Shen J; Song Z; Wang M; Yang P; Wang Q; Feng G; Liu B; Sun W; Xu Q; Li B; He L; He G; Li W; Wen Z; Liu K; Huang F; Zhou J; Ji J; Li X; Shi Y
Biol Psychiatry; 2016 Aug; 80(4):331-337. PubMed ID: 26795442
[TBL] [Abstract][Full Text] [Related]
6. Genetic regulation of Nrxn1 [corrected] expression: an integrative cross-species analysis of schizophrenia candidate genes.
Mozhui K; Wang X; Chen J; Mulligan MK; Li Z; Ingles J; Chen X; Lu L; Williams RW
Transl Psychiatry; 2011 Jul; 1(7):e25. PubMed ID: 22832527
[TBL] [Abstract][Full Text] [Related]
7. Rare Copy Number Variants in NRXN1 and CNTN6 Increase Risk for Tourette Syndrome.
Huang AY; Yu D; Davis LK; Sul JH; Tsetsos F; Ramensky V; Zelaya I; Ramos EM; Osiecki L; Chen JA; McGrath LM; Illmann C; Sandor P; Barr CL; Grados M; Singer HS; Nöthen MM; Hebebrand J; King RA; Dion Y; Rouleau G; Budman CL; Depienne C; Worbe Y; Hartmann A; Müller-Vahl KR; Stuhrmann M; Aschauer H; Stamenkovic M; Schloegelhofer M; Konstantinidis A; Lyon GJ; McMahon WM; Barta C; Tarnok Z; Nagy P; Batterson JR; Rizzo R; Cath DC; Wolanczyk T; Berlin C; Malaty IA; Okun MS; Woods DW; Rees E; Pato CN; Pato MT; Knowles JA; Posthuma D; Pauls DL; Cox NJ; Neale BM; Freimer NB; Paschou P; Mathews CA; Scharf JM; Coppola G; ;
Neuron; 2017 Jun; 94(6):1101-1111.e7. PubMed ID: 28641109
[TBL] [Abstract][Full Text] [Related]
8. Sequence analysis of 17 NRXN1 deletions.
Enggaard Hoeffding LK; Hansen T; Ingason A; Doung L; Thygesen JH; Møller RS; Tommerup N; Kirov G; Rujescu D; Larsen LA; Werge T
Am J Med Genet B Neuropsychiatr Genet; 2014 Jan; 165B(1):52-61. PubMed ID: 24339137
[TBL] [Abstract][Full Text] [Related]
9. Identification of candidate single-nucleotide polymorphisms in NRXN1 related to antipsychotic treatment response in patients with schizophrenia.
Jenkins A; Apud JA; Zhang F; Decot H; Weinberger DR; Law AJ
Neuropsychopharmacology; 2014 Aug; 39(9):2170-8. PubMed ID: 24633560
[TBL] [Abstract][Full Text] [Related]
10. Identification of rare copy number variants in high burden schizophrenia families.
Van Den Bossche MJ; Strazisar M; Cammaerts S; Liekens AM; Vandeweyer G; Depreeuw V; Mattheijssens M; Lenaerts AS; De Zutter S; De Rijk P; Sabbe B; Del-Favero J
Am J Med Genet B Neuropsychiatr Genet; 2013 Apr; 162B(3):273-82. PubMed ID: 23505263
[TBL] [Abstract][Full Text] [Related]
11. CNV analysis in Tourette syndrome implicates large genomic rearrangements in COL8A1 and NRXN1.
Nag A; Bochukova EG; Kremeyer B; Campbell DD; Muller H; Valencia-Duarte AV; Cardona J; Rivas IC; Mesa SC; Cuartas M; Garcia J; Bedoya G; Cornejo W; Herrera LD; Romero R; Fournier E; Reus VI; Lowe TL; Farooqi IS; ; Mathews CA; McGrath LM; Yu D; Cook E; Wang K; Scharf JM; Pauls DL; Freimer NB; Plagnol V; Ruiz-Linares A
PLoS One; 2013; 8(3):e59061. PubMed ID: 23533600
[TBL] [Abstract][Full Text] [Related]
12. Truncating mutations in NRXN2 and NRXN1 in autism spectrum disorders and schizophrenia.
Gauthier J; Siddiqui TJ; Huashan P; Yokomaku D; Hamdan FF; Champagne N; Lapointe M; Spiegelman D; Noreau A; Lafrenière RG; Fathalli F; Joober R; Krebs MO; DeLisi LE; Mottron L; Fombonne E; Michaud JL; Drapeau P; Carbonetto S; Craig AM; Rouleau GA
Hum Genet; 2011 Oct; 130(4):563-73. PubMed ID: 21424692
[TBL] [Abstract][Full Text] [Related]
13. Rare variants in the genetic background modulate cognitive and developmental phenotypes in individuals carrying disease-associated variants.
Pizzo L; Jensen M; Polyak A; Rosenfeld JA; Mannik K; Krishnan A; McCready E; Pichon O; Le Caignec C; Van Dijck A; Pope K; Voorhoeve E; Yoon J; Stankiewicz P; Cheung SW; Pazuchanics D; Huber E; Kumar V; Kember RL; Mari F; Curró A; Castiglia L; Galesi O; Avola E; Mattina T; Fichera M; Mandarà L; Vincent M; Nizon M; Mercier S; Bénéteau C; Blesson S; Martin-Coignard D; Mosca-Boidron AL; Caberg JH; Bucan M; Zeesman S; Nowaczyk MJM; Lefebvre M; Faivre L; Callier P; Skinner C; Keren B; Perrine C; Prontera P; Marle N; Renieri A; Reymond A; Kooy RF; Isidor B; Schwartz C; Romano C; Sistermans E; Amor DJ; Andrieux J; Girirajan S
Genet Med; 2019 Apr; 21(4):816-825. PubMed ID: 30190612
[TBL] [Abstract][Full Text] [Related]
14. Genetic architecture of schizophrenia: a review of major advancements.
Legge SE; Santoro ML; Periyasamy S; Okewole A; Arsalan A; Kowalec K
Psychol Med; 2021 Oct; 51(13):2168-2177. PubMed ID: 33550997
[TBL] [Abstract][Full Text] [Related]
15. Neurexin-1 and frontal lobe white matter: an overlapping intermediate phenotype for schizophrenia and autism spectrum disorders.
Voineskos AN; Lett TA; Lerch JP; Tiwari AK; Ameis SH; Rajji TK; Müller DJ; Mulsant BH; Kennedy JL
PLoS One; 2011; 6(6):e20982. PubMed ID: 21687627
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of NRXN1 deletions from 19,263 clinical microarray cases identifies exons important for neurodevelopmental disease expression.
Lowther C; Speevak M; Armour CM; Goh ES; Graham GE; Li C; Zeesman S; Nowaczyk MJ; Schultz LA; Morra A; Nicolson R; Bikangaga P; Samdup D; Zaazou M; Boyd K; Jung JH; Siu V; Rajguru M; Goobie S; Tarnopolsky MA; Prasad C; Dick PT; Hussain AS; Walinga M; Reijenga RG; Gazzellone M; Lionel AC; Marshall CR; Scherer SW; Stavropoulos DJ; McCready E; Bassett AS
Genet Med; 2017 Jan; 19(1):53-61. PubMed ID: 27195815
[TBL] [Abstract][Full Text] [Related]
17. Disruption of the neurexin 1 gene is associated with schizophrenia.
Rujescu D; Ingason A; Cichon S; Pietiläinen OP; Barnes MR; Toulopoulou T; Picchioni M; Vassos E; Ettinger U; Bramon E; Murray R; Ruggeri M; Tosato S; Bonetto C; Steinberg S; Sigurdsson E; Sigmundsson T; Petursson H; Gylfason A; Olason PI; Hardarsson G; Jonsdottir GA; Gustafsson O; Fossdal R; Giegling I; Möller HJ; Hartmann AM; Hoffmann P; Crombie C; Fraser G; Walker N; Lonnqvist J; Suvisaari J; Tuulio-Henriksson A; Djurovic S; Melle I; Andreassen OA; Hansen T; Werge T; Kiemeney LA; Franke B; Veltman J; Buizer-Voskamp JE; ; Sabatti C; Ophoff RA; Rietschel M; Nöthen MM; Stefansson K; Peltonen L; St Clair D; Stefansson H; Collier DA
Hum Mol Genet; 2009 Mar; 18(5):988-96. PubMed ID: 18945720
[TBL] [Abstract][Full Text] [Related]
18. Rare loss-of-function variants in SETD1A are associated with schizophrenia and developmental disorders.
Singh T; Kurki MI; Curtis D; Purcell SM; Crooks L; McRae J; Suvisaari J; Chheda H; Blackwood D; Breen G; Pietiläinen O; Gerety SS; Ayub M; Blyth M; Cole T; Collier D; Coomber EL; Craddock N; Daly MJ; Danesh J; DiForti M; Foster A; Freimer NB; Geschwind D; Johnstone M; Joss S; Kirov G; Körkkö J; Kuismin O; Holmans P; Hultman CM; Iyegbe C; Lönnqvist J; Männikkö M; McCarroll SA; McGuffin P; McIntosh AM; McQuillin A; Moilanen JS; Moore C; Murray RM; Newbury-Ecob R; Ouwehand W; Paunio T; Prigmore E; Rees E; Roberts D; Sambrook J; Sklar P; St Clair D; Veijola J; Walters JT; Williams H; ; ; ; ; Sullivan PF; Hurles ME; O'Donovan MC; Palotie A; Owen MJ; Barrett JC
Nat Neurosci; 2016 Apr; 19(4):571-7. PubMed ID: 26974950
[TBL] [Abstract][Full Text] [Related]
19. A genome-wide study of common SNPs and CNVs in cognitive performance in the CANTAB.
Need AC; Attix DK; McEvoy JM; Cirulli ET; Linney KL; Hunt P; Ge D; Heinzen EL; Maia JM; Shianna KV; Weale ME; Cherkas LF; Clement G; Spector TD; Gibson G; Goldstein DB
Hum Mol Genet; 2009 Dec; 18(23):4650-61. PubMed ID: 19734545
[TBL] [Abstract][Full Text] [Related]
20. Functional impacts of NRXN1 knockdown on neurodevelopment in stem cell models.
Zeng L; Zhang P; Shi L; Yamamoto V; Lu W; Wang K
PLoS One; 2013; 8(3):e59685. PubMed ID: 23536886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
